Medicare weight loss drug pilot begins
A major expansion of Medicare coverage will offer select weight loss drugs for a $50 monthly co-pay, potentially benefiting up to 20 million eligible seniors.
The argument
The pilot program aims to lower the cost of these treatments from the previous $450 monthly co-pay. The government-funded initiative is scheduled to run through the end of next year, though its long-term viability depends on convincing private insurers to continue participating.
The thesis, stress-tested
✓ What validates it
- ✓Insurers agreeing to extend participation beyond the initial pilot period
- ✓Data showing high adoption rates among the 20 million eligible seniors
▸ Risks discussed
- ▸The program is currently only funded through the end of next year
- ▸Long-term viability depends on convincing private insurers to participate
Hear it yourself
"Also starting today, a major expansion of Medicare coverage. A pilot program will offer weight loss drugs for a $50 a month co pay, much cheaper than the $450 a month many seniors had to pay before. Up to 20,000,000 people in Medicare will likely be eligible."
00:00 / 00:17
AFFILIATE LINK · ZORTIX MAY EARN A COMMISSION · NEVER A RECOMMENDATION TO TRADE